Polypharmacology – the ability of a drug to affect more than one protein – should be studied early in the drug discovery pathway, and constantly monitored as the chemical structure is optimised in the design of the clinical candidate, leading researchers believe.

Scientists have created a dynamic database driven by artificial intelligence which is collecting together the world’s research on coronavirus in a single online space.

Staff and students from across The Institute of Cancer Research, London, are using their scientific and clinical expertise as part of the national response to the coronavirus pandemic.